Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25289
Title: Effect of liver transplantation on QT-interval prolongation and impact on mortality.
Austin Authors: Ko, Jefferson ;Koshy, Anoop N ;Han, Hui-Chen ;Weinberg, Laurence ;Gow, Paul J ;Testro, Adam G ;Lim, Han S ;Farouque, Omar ;Teh, Andrew W 
Affiliation: Department of Cardiology, Eastern Health Clinical School, Monash University, Victoria, Australia
Anaesthesia
Victorian Liver Transplant Unit
Cardiology
The University of Melbourne, Parkville, Victoria, Australia
Issue Date: 10-Nov-2020
metadata.dc.date: 2020-11-10
Publication information: International Journal of Cardiology 2020; online first: 11 November
Abstract: QT-interval prolongation is considered the electrophysiological hallmark of cirrhotic cardiomyopathy. However, the significance of QT-interval prolongation and how it is affected by liver transplantation (LT) remains unclear. Consecutive inpatients undergoing LT between 2010 and 2017 at a state-wide liver transplant center in Australia were included. Preoperative, early postoperative and long-term follow-up corrected QT-intervals (QTc) were manually measured by a cardiologist. QTc was calculated using the Bazett formula and QTc ≥440 milliseconds (ms) was considered prolonged. Overall, 1111 ECG tracings among 408 patients (mean age 57 ± 12 years) were assessed. Pre-LT, 265 patients (65.0%) had QTc ≥440 ms and 24 patients (5.9%) had QTc ≥500 ms. In the early postoperative period, there was a significant increase in QTc compared to pre-LT (471 ± 39 vs. 452 ± 31 ms, p < 0.001) and 80 patients (20.3%) had QTc ≥500 ms. At a median of six months post-LT, there was significant reduction in mean QTc compared to pre-LT (430 ± 32 vs. 452 ± 31 ms; p < 0.001) with the QTc shortening in 73% of patients. QT-interval prolongation was not associated with postoperative complications or mortality at any time-point. QT-interval prolongation is common in patients with liver cirrhosis and this metric normalized in the majority within six months post-LT. A significant increase in QTc was noted early post-LT, with over 20% demonstrating QTc ≥500 ms. QT-interval prolongation was not associated with post-transplant complications or mortality. Resolution of QT-interval prolongation suggests that this feature of cirrhotic cardiomyopathy may reverse post-transplantation.
URI: https://ahro.austin.org.au/austinjspui/handle/1/25289
DOI: 10.1016/j.ijcard.2020.11.017
PubMed URL: 33186663
Type: Journal Article
Subjects: Cirrhosis
Cirrhotic cardiomyopathy
Liver disease
Liver transplantation
QT interval
Appears in Collections:Journal articles

Show full item record

Page view(s)

26
checked on Apr 17, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.